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Abstract
Objective To investigate the associations of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with changes in
knee cartilage composition and joint structure over 48 months, using magnetic resonance imaging (MRI) data from the
Osteoarthritis Initiative (OAI).
Materials and methods A total of 1126 participants with right knee Kellgren-Lawrence (KL) score 0–2 at baseline, no history of
rheumatoid arthritis, blood pressure measurements at baseline, and cartilage T2 measurements at baseline and 48 months were
selected from the OAI. Cartilage composition was assessed using MRI T2 measurements, including laminar and gray-level co-
occurrence matrix texture analyses. Structural knee abnormalities were graded using the whole-organ magnetic resonance
imaging score (WORMS). We performed linear regression, adjusting for age, sex, body mass index, physical activity, smoking
status, alcohol use, KL score, number of anti-hypertensive medications, and number of nonsteroidal anti-inflammatory drugs.
Results Higher baseline DBP was associated with greater increases in global T2 (coefficient 0.22 (95% CI 0.09, 0.34), P =
0.004), global superficial layer T2 (coefficient 0.39 (95% CI 0.20, 0.58), P = 0.001), global contrast (coefficient 15.67 (95% CI
8.81, 22.53), P < 0.001), global entropy (coefficient 0.02 (95% CI 0.01, 0.03) P = 0.011), and global variance (coefficient 9.14
(95% CI 5.18, 13.09), P < 0.001). Compared with DBP, the associations of SBP with change in cartilage T2 parameters and
WORMS subscores showed estimates of smaller magnitude.
Conclusion Higher baseline DBP was associated with higher and more heterogenous cartilage T2 values over 48 months,
indicating increased cartilage matrix degenerative changes.
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Introduction
Osteoarthritis (OA) is a highly prevalent, disabling musculo-
skeletal disorder [1]. Current treatment options for OA are
limited and primarily target the symptoms and disability
caused by OA [1, 2]. Due to the chronic nature of OA and
lack of longitudinal studies investigating OA biomarkers, our
understanding of risk factors for the early development of OA
is limited.
Given its potential significance in improving OA preven-
tative strategies, there has been growing interest in studying
the association of OAwith metabolic syndrome (MS). Several
studies have shown associations between OA and MS com-
ponents, including systolic blood pressure (SBP) and diastolic
blood pressure (DBP) [3–8]. Lo et al. showed that high SBP
was associated with increased incidence of radiographic knee
OA [5]. Another study investigating the relationship of MS
components with radiographic knee OA in the Framingham
Offspring cohort reported an association between high DBP
and incident radiographic OA [6]. Many of the previous stud-
ies classified subjects based on radiographic measures, which
are generally insensitive for early and mild OA. Furthermore,
we have not found any studies that evaluated the association
of blood pressure with knee cartilage composition and mor-
phological changes as assessed with magnetic resonance im-
aging (MRI).
MRI-based T2 relaxation time measurement is a quan-
titative imaging technique that characterizes the biochem-
ical properties of cartilage composition and measures ear-
ly degenerative changes in the cartilage extracellular ma-
trix [9]. Several studies have demonstrated that, in addi-
tion to mean T2, the laminar organization and spatial dis-
tribution of T2 values may be important when investigat-
ing early OA pathogenesis [10–13]. Laminar analysis,
which partitions knee cartilage into a deep bone layer
and a superficial articular layer, measures early laminar
disruption within cartilage that may occur prior to chang-
es in full-thickness cartilage mean T2 values [12]. Gray-
level co-occurrence matrix (GLCM) texture analysis eval-
uates the spatial distribution of T2 values. GLCM texture
parameters (contrast, entropy, variance) supplement stan-
dard T2 measurements by providing information at a pixel
level and measuring cartilage heterogeneity. Higher con-
trast, entropy, and variance are associated with a more
inhomogeneous cartilage texture and are features of early
degenerative changes when there is more fluid in the car-
tilage and a more heterogeneous collagen architecture.
The goals of our study were therefore to investigate wheth-
er SBP and DBP are associated with changes in knee cartilage
composition and structural knee abnormalities over 48months,
assessed using MRI-based T2 relaxation time measurements
and modified whole-organ magnetic resonance imaging
scores (WORMS), respectively.
Materials and methods
Study participants and selection
The Osteoarthritis Initiative (OAI) is a multicenter, longitudi-
nal observational study of the evolution of OA. The OAI
enrolled 4796 study participants ages 45–79 years with either
risk factors for the development of knee OA, established
symptomatic knee OA, or no OA risk factors. The aim of
the OAI is to establish a public domain research resource for
investigating and validating biomarkers of knee OA onset and
progression, including those derived from MRI (https://data-
archive.nimh.nih.gov/oai). Informed consent was reviewed
and approved for each participant by the local institutional
review board of the OAI participating center.
In this study, we selected OAI participants who had no or
mild radiographic tibiofemoral OA (Kellgren-Lawrence (KL)
score 0–2) in the right knee at baseline, blood pressure mea-
surements at baseline, and cartilage T2 measurements in the
right knee at baseline and 48months (Fig. 1). Participants with
a history of rheumatoid arthritis or another inflammatory ar-
thropathy were excluded. Participants with radiographic KL
score ≥ 3 in the right knee were excluded given that previous
studies have shown T2 measurements may be limited for the
evaluation of cartilage degeneration once advanced cartilage
loss occurs [14]. T2 measurements and WORMS were ana-
lyzed in prior studies with different aims from the current
study [14–22]. Based on our inclusion and exclusion criteria,
right knees from 1126 participants were selected and
analyzed.
Blood pressure measurements
Blood pressure measurements in the OAI study protocol
closely followed the Seventh Report of the Joint National
Committee on Prevention, Detection, Evaluation, and
Fig. 1 Flowchart demonstrating participant selection from the
osteoarthritis initiative (OAI). KL, Kellgren-Lawrence
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Treatment of High Blood Pressure (JNC7) [23] and were
assessed by trained OAI staff using the auscultatory method.
Participants were asked to avoid drinking caffeine, exercising,
or smoking for at least 30 min prior to blood pressure assess-
ment. Furthermore, participants were asked to sit in a chair
with feet on the floor and arm supported at heart level for at
least 5 min prior to measurement. An estimated SBP was first
measured using the palpated radial obliteration pressure, and
subsequently, an appropriately sized cuff was inflated 20–
30 mmHg above this level for auscultatory determination.
SBP and DBP were measured using a conventional mercury
sphygmomanometer and stethoscope. Blood pressure mea-
surements from the OAI baseline, 12-, 24-, 36- and 48-
month visits, were used in this study. These data are publicly
available (AllClinical_SAS, versions 0.2.2, 1.2.1, 3.2.1,
5.2.1).
Participant characteristics
For all participants that fulfilled the selection criteria, age,
gender, body mass index (BMI), Physical Activity Scale for
the Elderly (PASE), smoking status, and alcohol use at base-
line were collected. These data are publicly available
(AllClinical_SAS, version 0.2.2; Enrollees_SAS, version 22).
Medications
Information about prescription medication use was obtained
using a standardized medication inventory form for the OAI.
Participants brought in all medications that they took during
the 30 days preceding the OAI baseline visit. Medications
were classified and coded using the Iowa Drug Information
System ingredient database. Medication inventory data were
reviewed to identify anti-hypertensive medications (AHM)
whose primary indication was the treatment of hypertension
including beta blockers, angiotensin-converting enzyme in-
hibitors, angiotensin II receptor blockers, thiazides,
chlorthalidone, dihydropyridine calcium channel blockers,
and aliskiren. Nonsteroidal anti-inflammatory drugs
(NSAID), which are known to increase blood pressure [24],
were also identified including ibuprofen, flurbiprofen,
naproxen, oxaprozin, celecoxib, rofecoxib, valdecoxib,
diclofenac, sulindac, etodolac, ketorolac, nabumetone, indo-
methacin, tolmetin, piroxicam, and meloxicam. These data are
publicly available (MIF00_SAS, version 0.2.2).
MRI protocol
MR images were acquired using four 3.0T scanners (Siemens
Magnetom Trio; Siemens Healthcare, Erlangen, Germany)
with quadrature transmit-receive coils (USA Instruments,
Aurora, OH, USA) at the OAI clinical sites. For cartilage T2
measurements, a sagittal 2D multislice multiecho (MSME)
sequence (echo times [TE] = 10–70 ms; repetition time
[TR] = 2700 ms) was used. The following sequences were
used for analysis of structural knee abnormalities: a sagittal
2D intermediate-weighted (IW) fat-suppressed turbo spin-
echo (TSE) sequence (TR = 3200 ms; TE = 30 ms), a coronal
2D IW non-fat-suppressed TSE sequence (TR = 3700 ms;
TE = 29 ms), and a 3D dual echo steady-state gradient-echo
with selective water excitation sequence (TR = 16.3 ms; TE =
4.7 ms). Details regarding the MR acquisition protocols have
been described previously [25].
Image analysis
Radiographic KL score
Fixed flexion knee radiographs were obtained at the OAI
baseline visit and central readers assessed radiographic sever-
ity in the tibiofemoral compartment using the Kellgren-
Lawrence (KL) score [26]. Participants with KL score 0 (no
radiographic features of OA), KL score 1 (doubtful joint space
narrowing with possible osteophytes), and KL score 2 (possi-
ble joint space narrow with definite osteophytes) in the right
knee at baseline were selected. Baseline radiographic KL
scores are publicly available (kXR_SQ_BU00_SAS, version
0.8).
T2 measurements
For T2 analysis, semiautomatic cartilage segmentation of five
knee regions (patella, lateral/medial femur, and lateral/medial
tibia) was performed using an in-house, spline-based algo-
rithm written in MatLab (MathWorks, Natick, MA) as de-
scribed previously [19]. The trochlear region was excluded
from the analysis due to interfering flow artifacts from the
popliteal artery. Furthermore, cartilage sections with compro-
mised image quality or artifacts limiting segmentation were
excluded from the analysis. T2 maps were computed from the
MSME images on a pixel-by-pixel basis using six echoes
(TE = 20–70 ms) after excluding the first echo in order to
optimize the signal-to-noise ratio [27–30]. Mean T2 values
were computed for each cartilage region, and the global T2
values were computed as the mean of all knee regions.
Laminar and GLCM texture analyses
Laminar analysis divided the cartilage of each segmented re-
gion into two layers of equal thickness: a superficial articular
layer and a deep bone layer adjacent to the cartilage-bone
interface [12]. In addition, texture analysis was performed to
assess the gray-level distributions of pixels based on the
GLCM as described by Haralick et al. [31]. Based on our
previous work, three GLCM texture parameters were included
in the analysis: contrast, entropy, and variance [32]. Contrast
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is a measure of the differences in neighboring pixel values
with higher contrast indicating a greater probability of neigh-
boring pixels with large differences in T2 values. Entropy
represents the probability of finding another pixel pair with
the same value in the entire image. A higher entropy suggests
a more random distribution of T2 values. Variance is a mea-
sure of the distribution of pixel values about the region mean.
Therefore, a higher variance reflects a high number of pixels
with T2 values dispersed from the mean T2.
WORMS scoring
MR images of the right knee at baseline and 48 months were
previously graded using the modified semi-quantitative
whole-organ magnetic resonance imaging score (WORMS)
[33]. The modified WORMS has been described in detail in
earlier studies [15–17, 20] and assesses structural abnormali-
ties of the knee joint on a numeric grading system, with higher
scores indicating increased severity of morphological find-
ings. Structural abnormalities included cartilage lesions, bone
marrow edema pattern (BMEP), and effusion. Cartilage le-
sions (graded 0–6) and BMEP (graded 0–4) were assessed
in the same six regions (patella, lateral/medial femur, lateral/
medial tibia, trochlea). Effusion was scored according to
WORMS as previously described [33]. For cartilage lesions
and BMEP, the WORMS max score was defined as the max-
imum lesion score in any knee region.
Reproducibility
Cartilage T2 and WORMS reproducibility results have been
described previously [19, 21, 22]. To assess inter- and
intrareader reproducibilities for cartilage T2 measurements,
coefficients of variation (CV) were calculated on a percentage
basis as the root mean square average. The interreader repro-
ducibility error for mean T2 across ranged from 1.2% in the
patella to 1.9% in the lateral tibia [19]. The intrareader repro-
ducibility for mean T2 ranged from 0.8% in the medial femur
to 3.2% in the patella [21].
Three radiologists with 8, 6, and 6 years of experience
performed WORMS readings; each study was read by two
radiologists independently and both were blinded to clinical
data. In equivocal cases, a consensus reading was performed
with a musculoskeletal radiologist with 25 years of experi-
ence. For interreader reproducibility of WORMS readings,
the intraclass correlation coefficients (ICC) ranged from 0.97
(95% CI 0.95–0.98) for WORMS cartilage to 0.75 (95% CI
0.52–0.86) for WORMS effusion [22]. The ICCs for
intrareader reproducibility ranged from 0.99 (95% CI 0.98–
0.99) and 0.99 (95% CI 0.99–0.99) for WORMS cartilage to
0.90 (95% CI 0.81–0.94) and 0.74 (95% CI 0.52–0.86) for
WORMS effusion [22]. Similar inter- and intrareader repro-
ducibilities have been published previously [15, 20].
Statistical analysis
Statistical analysis was performed using Stata software
(Version 15, College Station, TX, USA; StataCorp LP).
Linear regression models were performed using standardized
values for baseline SBP and DBP as primary predictors and
change in cartilage T2 andWORMSsubscores over 48months
as primary outcomes. To make interpretation easier, we report
standardized coefficients—the change in outcome per stan-
dard deviation change in the predictors. Standardized values
for predictors were calculated by subtracting the mean value
across all participants from the value for each participant and
dividing by the standard deviation. Based on prior analyses [8,
17, 18, 32], the change in laminar parameters (superficial layer
T2, deep layer T2) and change in GLCM texture parameters
(contrast, entropy, variance) over 48 months were considered
as secondary outcomes. Models were adjusted for baseline
age, sex, BMI, PASE, smoking status, alcohol use, KL score,
number of anti-hypertensive medications (AHMs), and num-
ber of nonsteroidal anti-inflammatory drugs (NSAIDs) report-
ed at baseline. All predictors, outcomes, and covariates (ex-
cept sex, smoking status, alcohol use) were analyzed as con-
tinuous variables. Furthermore, we performed a sensitivity
analysis to assess whether the results differed when the blood
pressure for each participant was averaged across five visits.
Average SBP and DBP were calculated as the mean of base-
line, 12-, 24-, 36- and 48-month SBP and DBP measurements
for each participant, respectively. Standardized values for av-
erage SBP and DBP were subsequently calculated as previ-
ously described. We conducted an additional sensitivity anal-
ysis to test the robustness of our results, excluding participants
with mild radiographic tibiofemoral OA in either knee (KL ≥
2). To evaluate whether the associations of SBP and DBPwith
change in cartilage T2, laminar parameters, GLCM texture
parameters, and WORMS subscores were modified by num-
ber of AHMs, we included interaction terms between number
of AHMs and SBP and DBP. Models with and without these
interaction terms were compared using the likelihood ratio
test. In addition, linear regression models were assessed for
departures from linearity using component-plus-residual
plots. P values were adjusted for multiple comparisons across
all models using the Benjamini-Hochberg procedure. Two-
way false discovery rate (FDR) adjusted P values < 0.05 were
considered statistically significant.
Results
Participant characteristics
Participant characteristics are summarized in Table 1. The
average age of all study participants was 58.8 (8.7) years with
a higher proportion of females (59.1%). The average BMI was
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28.3 (4.4) kg/m2, the average SBP was 122.4 (15.4) mmHg,
and the average DBP was 75.4 (9.7) mmHg. A total of 408
(36.2%) participants reported taking at least one AHM, and
170 (15.1%) participants reported taking at least one NSAID
at baseline.
Change in cartilage T2 and laminar parameters
over 48 months
A one standard deviation increase in baseline DBP
(9.66 mmHg) was associated with greater increases in global
T2 (coefficient 0.22 (95% CI 0.09, 0.34), FDR-adjusted P =
0.004; Fig. 2) and global superficial layer T2 (coefficient 0.39
(95%CI 0.20, 0.58), FDR-adjustedP = 0.001) over 48months
as shown in Table 2. This suggests that an increase in baseline
DBP was associated with worsening of T2 values and in-
creased degeneration in the global and superficial layers of
knee cartilage. Compared with baseline DBP, a weaker effect
was observed for the associations of baseline SBPwith chang-
es in global T2, global deep layer T2, and global superficial
layer T2. Similar results were observed when using average
SBP and DBP as predictors (Online Resource 1).
Change in GLCM texture parameters over 48 months
As shown in Table 2, higher baseline DBP was associated
with greater increases in GLCM global contrast (coefficient
15.67 (95% CI 8.81, 22.53), FDR-adjusted P < 0.001),
GLCM global entropy (coefficient 0.02 (95% CI 0.01, 0.03),
FDR-adjusted P = 0.01), and GLCM global variance
Table 1 Baseline descriptive
characteristics of participants All participants (n = 1126)
Age, mean (SD) years 58.8 (8.7)
Body mass index, mean (SD) kg/m2 28.3 (4.4)
Female, n (%) 666 (59.1)
Physical Activity Scale for the Elderly, mean (SD) 167.0 (83.1)
Smoking status, n (%)
Never 647 (57.7)
Former 50 (4.5)
Current 423 (37.7)
Current, but never regular 2 (0.2)
Alcohol use, n (%) 911 (81.1)
Right knee Kellgren-Lawrence, n (%)
Grade 0 538 (47.8)
Grade 1 268 (23.8)
Grade 2 320 (28.4)
WOMAC pain score (range, 0–20), mean (SD) 1.7 (2.7)
Systolic blood pressure, mean (SD) mmHg 122.4 (15.4)
Systolic blood pressure, min–max mmHg 82–180
Diastolic blood pressure, mean (SD) mmHg 75.4 (9.7)
Diastolic blood pressure, min–max mmHg 50–110
Number of AHMs, n (%)
0 718 (63.8)
1 223 (19.8)
2 134 (11.9)
3 43 (3.8)
4 6 (0.5)
5 2 (0.2)
Number of NSAIDs, n (%)
0 956 (84.9)
1 160 (14.2)
2 10 (0.9)
Data are given as means (standard deviation), n (% of total), or range (minimum to maximum)
WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index; AHM, anti-hypertensive medication;
NSAID, nonsteroidal anti-inflammatory drug
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(coefficient 9.14 (95% CI 5.18, 13.09), FDR-adjusted
P < 0.001) over 48 months. This indicates that an increase in
baseline DBP was associated with more heterogenous carti-
lage T2 values, suggesting a more disordered cartilage
composition. Similar results were observed when using aver-
age SBP and DBP over the five visits as predictors except for
the association of average DBP with change in GLCM global
entropy which was no longer significant after adjustment for
Fig. 2 Representative T2 color
maps (values are in milliseconds)
overlaid on sagittal 2D multislice
multiecho (MSME) sequences
showing the lateral knee com-
partment in a study participant
with a diastolic blood pressure
(DBP) of 94 mmHg (a, b) and a
participant with a DBP of
58 mmHg (c, d) over 48 months.
Blue color represents lower T2
values while red represents higher
T2 values. In comparison with the
T2 color map at baseline showing
predominantly lower T2 values
(a), the T2 color map of the par-
ticipant with the DBP of
94 mmHg shows overall elevated
T2 values in the cartilage of the
lateral femoral condyle and lateral
tibia after 48 months (b) indicat-
ing progressive cartilage matrix
degeneration. The T2 color maps
of the participant with the DBP of
58 mmHg show predominately
lower T2 values at both time
points (c, d)
Table 2 Association of baseline systolic blood pressure (SBP) and baseline diastolic blood pressure (DBP) with longitudinal change in cartilage T2,
laminar parameters, and GLCM texture parameters over 48 months
Change in cartilage T2 parameters over 48 months Adjusted for baseline age, sex, BMI, PASE, smoking status, alcohol use, KL score, number of
AHMs, and number of NSAIDs
SBP DBP
Coeff. (95% CI) P* Coeff. (95% CI) P*
Global knee T2 0.08 (− 0.05, 0.21) 0.48 0.22 (0.09, 0.34) 0.004
Global deep layer T2 0.08 (− 0.09, 0.25) 0.59 0.18 (0.02, 0.35) 0.12
Global superficial layer T2 0.18 (− 0.02, 0.37) 0.23 0.39 (0.20, 0.58) 0.001
Global contrast 4.78 (− 2.22, 11.78) 0.43 15.67 (8.81, 22.53) < 0.001
Global entropy 0.00 (− 0.01, 0.01) 0.96 0.02 (0.01, 0.03) 0.01
Global variance 1.76 (− 2.28, 5.80) 0.62 9.14 (5.18, 13.09) < 0.001
Data are given as coefficients (Coeff.) associated with a one standard deviation increase in baseline SBP (15.41 mmHg) or baseline DBP (9.66 mmHg)
with (95% confidence intervals) and computed as the absolute change between baseline and 48months. False discovery rate (FDR) was controlled using
the Benjamini-Hochberg procedure
GLCM, gray-level co-occurrence matrix; BMI, body mass index; PASE, Physical Activity Scale for the Elderly; KL, Kellgren-Lawrence; AHM, anti-
hypertensive medication; NSAID, nonsteroidal anti-inflammatory drug
* FDR-adjusted P values < 0.05 are in italics
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multiple comparisons (Online Resource 1). Compared with
baseline DBP, the associations of baseline SBP with changes
in global contrast, global entropy, and global variance over
48 months demonstrated estimates of smaller magnitude.
Furthermore, there was no evidence of departures from line-
arity in the associations of baseline DBP and SBPwith change
in cartilage T2, laminar parameters, and GLCM texture
parameters.
Change in WORMS subscores over 48 months
There were no strong associations of baseline SBP or baseline
DBP with changes in WORMS subscores (Table 3). Similar
results were observed in the models using average SBP and
DBP as predictors (Online Resource 2).
In a sensitivity analysis excluding participants with KL ≥ 2 in
either knee, the estimates of the associations of baselineDBPwith
change in cartilage T2 andWORMS subscores were consistent in
direction though they were smaller in magnitude. There was no
consistent evidence for interactions between number of AHMs
and either SBP or DBP for change in cartilage T2, laminar pa-
rameters, GLCM texture parameters, andWORMS subscores (all
FDR-adjusted P values for likelihood ratio test > 0.05).
Discussion
This study investigated the associations of SBP and DBP with
changes in knee articular cartilage composition using MRI T2
relaxation time measures and structural knee abnormalities
over 48 months as endpoints. Higher DBP was associated
with greater increases in cartilage T2 parameters, suggesting
accelerated deterioration of the cartilage matrix and a more
heterogenous cartilage composition.
Previous studies have reported associations of hyperten-
sion with incident knee OA after adjustment for BMI [3–6].
The Research on Osteoarthritis and Osteoporosis Disability
study reported that hypertension was associated with radio-
graphic knee OA occurrence and progression [3]. Moreover,
higher SBP but not DBP was associated with knee OA occur-
rence and progression; however, this association did not per-
sist after adjustment for other MS components. Hussain et al.
found that hypertension was associated with increased inci-
dence of severe knee OA requiring total knee replacement [4].
In a meta-analysis of eight studies, Zhang et al. reported that
there was a significant relationship between hypertension and
radiographic and symptomatic knee OA [7]. A previous study
from our group investigating the association of metabolic risk
factors with cartilage degeneration assessed by T2 relaxation
time demonstrated that hypertension was individually associ-
ated with baseline T2 [8]. Nonetheless, this association did not
persist after adjustment for BMI. In the OAI cohort, Lo et al.
demonstrated that high SBP, but not DBP, was associated with
incident radiographic OA [5]. Furthermore, participants tak-
ing three or more anti-hypertensive medications had de-
creased odds of developing incident OA compared with those
not taking any anti-hypertensive medications [5]. The
Framingham OA study reported an association of high DBP
with incident radiographic OA, and the relationship between
high SBP and incident radiographic OAwas nearly significant
as well [6]. Our results did not show a strong association of
SBP with change in knee cartilage composition and structural
abnormalities. In addition, there was no consistent evidence
for interactions between number of AHMs and SBP and DBP
for our outcomes. In contrast to previous studies which used
either arthroplasty or radiographs as outcome measures for
incident knee OA, our study utilized MRI-based parameters
to assess longitudinal changes in cartilage composition and
Table 3 Association of baseline systolic blood pressure (SBP) and baseline diastolic blood pressure (DBP) with longitudinal change in WORMS
subscores over 48 months
Change in WORMS subscores over 48 months Adjusted for baseline age, sex, BMI, PASE, smoking status, alcohol use, KL score, number of AHMs
and number of NSAIDs
SBP DBP
Coeff. (95% CI) P* Coeff. (95% CI) P*
WORMS cartilage max 0.07 (− 0.03, 0.17) 0.37 0.06 (− 0.03, 0.15) 0.47
WORMS BMEP max 0.03 (− 0.03, 0.10) 0.56 0.02 (− 0.04, 0.08) 0.71
WORMS effusion 0.04 (0.00, 0.07) 0.23 0.04 (0.01, 0.08) 0.09
Data are given as coefficients (Coeff.) associated with a one standard deviation increase in baseline SBP (15.41 mmHg) or baseline DBP (9.66 mmHg)
with (95% confidence intervals) and computed as the absolute change between baseline and 48 months. WORMS max scores were defined as the
maximum lesion score in any knee region. False discovery rate (FDR) was controlled using the Benjamini-Hochberg procedure
BMI, bodymass index;PASE, Physical Activity Scale for the Elderly;KL, Kellgren-Lawrence;AHM, anti-hypertensivemedication;NSAID, nonsteroidal
anti-inflammatory drug; BMEP, bone marrow edema pattern
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structural abnormalities. Nonetheless, there may still be po-
tential associations of SBP with change in knee cartilage com-
position and structural abnormalities that we were not able
detect in this study due to insufficient statistical power.
Compared with the estimates of the associations of DBP with
change in cartilage T2 parameters, the estimates for SBP were
generally smaller in magnitude though in the same direction
with overlapping confidence intervals.
The mechanism of the relationship between blood pressure
and OA is unclear. Hypertension is more prevalent among in-
dividuals with OA, and the two diseases share multiple risk
factors, including age, obesity, and other cardiovascular risk
factors [34]. There is growing evidence supporting the role of
vascular pathology in OA development and progression [35,
36]. Hypertension promotes microvasculature remodeling
which may lead to reduced blood flow to subchondral bone
and compromised nutrient and oxygen exchange into articular
cartilage [35–37]. Given that hypertension confers a
prothrombotic state [38], thrombotic blockage of microvascu-
lature would further potentiate the deleterious effects of im-
paired subchondral perfusion. In animal models, spontaneously
hypertensive rats had altered subchondral bone structure, thin-
ner hyaline cartilage, superficial disruption to the articular sur-
faces, and other OA-like lesions compared with control rats
[39]. It is intriguing that the associations of DBP with change
in cartilage composition were stronger than those of SBP with
change in cartilage composition. DBP, a reflection of peripheral
vascular resistance, may be a more important determinant of
small artery structure and media-to-lumen ratio than SBP [40].
Cartilage T2 parameters quantify the early biochemical
stages of cartilage degeneration and have both clinical and
prognostic significance. Elevated cartilage T2 values are as-
sociated with increased cartilage degeneration [41] and knee
pain [20] and can predict morphological degeneration [21]
and radiographic OA [10]. Carballido-Gamio et al. reported
that GLCM entropy of cartilage T2 was higher in participants
with mild knee OA as compared with controls [42]. In addi-
tion, participants with risk factors for knee OA but without
symptomatic or radiographic OA were found to have higher
and more heterogenous cartilage T2 values compared with
healthy controls [17]. Thus, cartilage T2 parameters may serve
as useful biomarkers for OA and identification of OA-related
risk factors. The clinical significance of our results (e.g., a
0.22 increase in change in global T2 per 9.66 mmHg increase
in baseline DBP) is best understood in the context of other
longitudinal studies which reported increases of 0.04, 0.10,
and 0.02 in change in global T2 per one point increase in
WOMAC pain, stiffness, and disability over 48 months, re-
spectively [43]. Past studies have shown that targeting OA-
related risk factors, such as obesity, can prevent incidence and
progression of OA, relieve symptoms, and improve quality of
life [44]. Consequently, a greater understanding of how other
risk factors, such as hypertension, contribute to the
degenerative process of OAwould aid in developing effective
treatment and preventative strategies for knee OA.
We acknowledge that this study has a few limitations. First,
there are multiple factors that influence blood pressure, and
many of these were not available to be assessed in the OAI
including family history of hypertension, sodium intake, and
medication dosage. The observed associations do not establish
causality, and further studies, including Mendelian randomi-
zation studies, are necessary to assess causal relationships be-
tween blood pressure and knee osteoarthritis. Furthermore, we
could not assess the reliability of blood pressure measure-
ments used in our study. It is well established that blood pres-
sure values oscillate over the short-term [45] as well as long-
term periods [46]. Therefore, we aimed to reduce the influence
of blood pressure variability on our results in a sensitivity
analysis using the average SBP and DBP measurements for
each participant across the baseline, 12-, 24-, 36- and 48-
month visits. Moreover, issues related to variability in medi-
cation frequency and duration of use as well as confounding
by indication may account for why there was no strong evi-
dence for interactions between number of AHMs and SBP and
DBP observed in our study. Finally, data on smoking behavior
and alcohol intake in the OAI was self-reported and may have
been subject to recall bias and purposeful underreporting due
to social desirability biases.
In conclusion, this study showed that higher DBP was as-
sociated with greater increases in cartilage T2 parameters over
48 months, signifying accelerated cartilage degeneration.
While further mechanistic studies are needed to elucidate the
pathophysiology behind this relationship, these results are sig-
nificant given the lack of research on the association of blood
pressure with cartilage composition and joint structures as
well as clinical approaches for OA management.
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